We’ve opined before about the weird regulatory divide that sees life-saving technologies withheld from U.S. patients while being freely available in Europe. It seems the clinical community shares the view,as one physician/author shows her frustration at the continued unavailability of Abbott’s MitraClip.
medtech
FDA Clears First-To-Market Simultaneous Anesthetic Infusion and Wound Drainage Catheter System
Vital 5, LLC, a VentureMD portfolio company, has received clearance from the U. S. FDA for ReLeaf™, a first-to-market, dual function catheter system that provides simultaneous anesthetic infusion and wound drainage.
FDA Clears New Sizes Of Resolute Integrity Coronary Stent For Long Lesions Common Among Diabetes Patients
Medtronic, Inc. has announced that the U.S. FDA has approved the 34mm and 38mm lengths of the Resolute Integrity drug-eluting stent in diameters of 3.0mm, 3.5mm and 4.0mm. The longer lengths include an indication for patients with diabetes in whom longer lesions are common.